PhiChem(SZ:300398) Ju Chao Zi Xun·2025-05-29 03:33Group 1 - The company announced the approval of a proposal to change the funding direction of a terminated fundraising project to purchase patents from JNC Group [2] - The company raised a total of RMB 825 million through the issuance of convertible bonds, with a net amount of RMB 808.96 million after deducting issuance costs [2] - As of April 30, 2025, the company has utilized RMB 579.06 million of the raised funds, with a remaining balance of RMB 53.78 million in the account for the terminated OLED project [2] Group 2 - To enhance its strategic adjustment and optimize its industrial structure, the company plans to purchase 100% equity of two subsidiaries from JNC for RMB 170 million and acquire all related patents for RMB 212 million [3] - JNC will invest RMB 170 million in cash to subscribe to the increased registered capital of the company, acquiring a 5.1% stake, while the company waives its preemptive subscription rights [3] - The agreements include a transfer of all display-related patents to the company, with a licensing arrangement allowing JNC to use these patents outside mainland China [3] Group 3 - To improve the efficiency of fund usage, the company plans to allocate the remaining interest and cash management income of RMB 53.78 million from the terminated OLED project to pay for the patent acquisition from JNC [4]